Impact of spironolactone on longitudinal changes in health-related quality of life in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial. Circulation: 200. Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: The IRONOUT HF randomized clinical trial. JAMA. 2017; 317(19):1958- 201. Lim EA, Sohn HS, Lee H, Choi SE. Cost-utility of ferric carboxymaltose (Ferinject) for iron- deficiency anemia patients with chronic heart failure in South Korea. Cost Effectiveness & 202. Lord L, Dowswell G, Hewison A. The team for both sides? A qualitative study of change in heart failure services at three acute NHS Trusts. Health & Social Care in the Community. 203. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R et al. Utility of B- natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity 204. Lyng P, Persson H, H gg-Martinell A, H gglund E, Hagerman I, Langius-Ekl f A et al. Weight monitoring in patients with severe heart failure (WISH). A randomized controlled trial. European Journal of Heart Failure. 2012; 14(4):438-444 Chronic Heart Failure Reference list NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 205. Macdonald JE, Kennedy N, Struthers AD. Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment. Heart. 2004; 90(7):765-70 206. MacDonald MR, She L, Doenst T, Binkley PF, Rouleau JL, Tan RS et al. Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. European Journal of Heart Failure. 2015; 17(7):725-34 207. 